Citation: | Liang Ziming, Ye Linsen, Tang Hui, et al. Evaluation of clinical prognosis of liver transplant recipients of hepatocellular carcinoma complicated with microvascular invasion[J]. ORGAN TRANSPLANTATION, 2020, 11(3): 350-355. doi: 10.3969/j.issn.1674-7445.2020.03.005 |
[1] |
BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424. DOI: 10.3322/caac.21492.
|
[2] |
YANG JD, HAINAUT P, GORES GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(10):589-604. DOI: 10.1038/s41575-019-0186-y.
|
[3] |
谭晓宇, 陈晓兰, 林金铭, 等.机械灌注技术引领器官捐献与移植模式的变革——器官ICU时代即将到来?[J].器官移植, 2019, 10(4):453-458.DOI:10.3969/j.issn. 1674-7445.2019.04.018.
TAN XY, CHEN XL, LIN JM, et al. Mechine perfusion technology leads the transformation of organ donation and transplantation model: the age of organ ICU?[J]. Organ Transplant, 2019, 10(4):453-458. DOI: 10.3969/j.issn.1674-7445.2019.04.018.
|
[4] |
POMMERGAARD HC, ROSTVED AA, ADAM R, et al. Vascular invasion and survival after liver transplantation for hepatocellular carcinoma: a study from the European Liver Transplant Registry[J]. HPB (Oxford), 2018, 20(8):768-775. DOI: 10.1016/j.hpb.2018.03.002.
|
[5] |
胡月雷, 孙大伟, 骆飞翔, 等.单发肝细胞癌发生微血管侵犯的影响因素及预后分析[J].临床肝胆病杂志, 2018, 34(9):1911-1916.DOI: 10.3969/j.issn.1001-5256.2018.09.017.
HU YL, SUN DW, LUO FX, et al. Influencing factors for microvascular invasion in patients with single hepatocellular carcinoma and their prognosis[J]. J Clin Hepatol, 2018, 34(9):1911-1916. DOI:10.3969/j.issn. 1001-5256.2018.09.017.
|
[6] |
SUMIE S, KUROMATSU R, OKUDA K, et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors[J]. Ann Surg Oncol, 2008, 15(5):1375-1382. DOI: 10.1245/s10434-008-9846-9.
|
[7] |
SAYINER M, GOLABI P, YOUNOSSI ZM. Disease burden of hepatocellular carcinoma: a global perspective[J]. Dig Dis Sci, 2019, 64(4):910-917. DOI: 10.1007/s10620-019-05537-2.
|
[8] |
BERTUCCIO P, TURATI F, CARIOLI G, et al. Global trends and predictions in hepatocellular carcinoma mortality[J]. J Hepatol, 2017, 67(2):302-309. DOI: 10.1016/j.jhep.2017.03.011.
|
[9] |
XU X, CHEN J, WEI Q, et al. Clinical practice guidelines on liver transplantation for hepatocellular carcinoma in China (2018 edition) [J]. Hepatobiliary Pancreat Dis Int, 2019, 18(4):307-312. DOI: 10.1016/j.hbpd.2019.06.010.
|
[10] |
BENSON AB, D'ANGELICA MI, ABBOTT DE, et al. Guidelines insights: hepatobiliary cancers, version 2.2019[J]. J Natl Compr Canc Netw, 2019, 17(4):302-310. DOI: 10.6004/jnccn.2019.0019.
|
[11] |
GALLE PR, FORNER A, LLOVET JM, et al. EASL clinical practice guidelines: management of hepatocellular carcinoma[J]. J Hepatol, 2018, 69(1):182-236. DOI: 10.1016/j.jhep.2018.03.019.
|
[12] |
AZOULAY D, AUDUREAU E, BHANGUI P, et al. Living or brain-dead donor liver transplantation for hepatocellular carcinoma: a multicenter, western, intent-to-treat cohort study[J]. Ann Surg, 2017, 266(6):1035-1044. DOI: 10.1097/SLA.0000000000001986.
|
[13] |
ASSALINO M, TERRAZ S, GRAT M, et al. Liver transplantation for hepatocellular carcinoma after successful treatment of macrovascular invasion[J]. Transpl Int, 2020, DOI: 10.1111/tri.13586 [Epub ahead of print].
|
[14] |
YE L, KRIEGL L, REITER FP, et al. Prognostic significance and functional relevance of olfactomedin 4 in early-stage hepatocellular carcinoma[J]. Clin Transl Gastroenterol, 2020, 11(1):e00124. DOI: 10.14309/ctg.0000000000000124.
|
[15] |
SHEN JY, LI C, WEN TF, et al. Liver transplantation versus surgical resection for HCC meeting the Milan criteria: a propensity score analysis[J]. Medicine (Baltimore), 2016, 95(52):e5756. DOI: 10.1097/MD.0000000000005756.
|
[16] |
LI X, HUANG L, LENG X. Analysis of prognostic factors of more/equal to10 years of survival for liver cancer patients after liver transplantation[J]. J Cancer Res Clin Oncol, 2018, 144(12):2465-2474. DOI: 10.1007/s00432-018-2756-8.
|
[17] |
LAHAN-MARTINS D, PERALES SR, GALLANI SK, et al. Microvascular invasion in hepatocellular carcinoma: is it predictable with quantitative computed tomography parameters? [J]. Radiol Bras, 2019, 52(5):287-292. DOI: 10.1590/0100-3984.2018.0123.
|
[18] |
ANDREOU A, BAHRA M, SCHMELZLE M, et al. Predictive factors for extrahepatic recurrence of hepatocellular carcinoma following liver transplantation[J]. Clin Transplant, 2016, 30(7):819-827. DOI: 10.1111/ctr.12755.
|
[19] |
EGUCHI S, TAKATSUKI M, HIDAKA M, et al. Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection[J]. World J Surg, 2010, 34(5):1034-1038. DOI: 10.1007/s00268-010-0424-5.
|
[20] |
GOH BK, CHOW PK, TEO JY, et al. Number of nodules, Child-Pugh status, margin positivity, and microvascular invasion, but not tumor size, are prognostic factors of survival after liver resection for multifocal hepatocellular carcinoma[J]. J Gastrointest Surg, 2014, 18(8):1477-1485. DOI: 10.1007/s11605-014-2542-0.
|
[21] |
YANG P, SI A, YANG J, et al. A wide-margin liver resection improves long-term outcomes for patients with HBV-related hepatocellular carcinoma with microvascular invasion[J]. Surgery, 2019, 165(4):721-730. DOI: 10.1016/j.surg.2018.09.016.
|
[22] |
GIARD JM, MEHTA N, DODGE JL, et al. Alpha-fetoprotein slope > 7.5 ng/ml per month predicts microvascular invasion and tumor recurrence after liver transplantation for hepatocellular carcinoma[J]. Transplantation, 2018, 102(5):816-822. DOI: 10.1097/TP.0000000000002094.
|
[23] |
IGUCHI T, SHIRABE K, AISHIMA S, et al. New pathologic stratification of microvascular invasion in hepatocellular carcinoma: predicting prognosis after living-donor liver transplantation[J]. Transplantation, 2015, 99(6):1236-1242. DOI: 10.1097/TP.0000000000000489.
|
[24] |
NITTA H, ALLARD MA, SEBAGH M, et al. Predictive model for microvascular invasion of hepatocellular carcinoma among candidates for either hepatic resection or liver transplantation[J]. Surgery, 2019, 165(6):1168-1175. DOI: 10.1016/j.surg.2019.01.012.
|
[25] |
REGINELLI A, VANZULLI A, SGRAZZUTTI C, et al. Vascular microinvasion from hepatocellular carcinoma: CT findings and pathologic correlation for the best therapeutic strategies[J]. Med Oncol, 2017, 34(5):93. DOI: 10.1007/s12032-017-0949-7.
|
[26] |
FAN J, YANG GS, FU ZR, et al. Liver transplantation outcomes in 1, 078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China[J]. J Cancer Res Clin Oncol, 2009, 135(10):1403-1412. DOI: 10.1007/s00432-009-0584-6.
|